Enterosgel - before you go to the doctor!

Section for doctors

Enterosgel eliminates harmful substances of exogenous and endogenous origin from the body. It enhances the restoration of intestinal microbiocenosis and mucosal regeneration.
The broad indication spectrum of Enterosgel use is adequate to the role of the gastrointestinal tract in the development of various diseases:

GASTROENTEROLOGY - peptic and duodenal ulcerations, irritable colon syndrome, inflammatory diseases of the small and large intestines, malabsorption syndrome, pathological conditions accompanied by impaired natural composition of intestinal microflora.
INFECTIOUS DISEASES - viral and bacterial enteritis, enterocolitis, colitis, and gastroenteritis of various types (salmonellosis, dysentery, rotaviral gastroenteritis), viral hepatitis of various types.
ALLERGOLOGY - atopic dermatitis, acute and chronic hives, bronchial asthma, allergic inflammation of the nasal mucosa, food allergies.
NEPHROLOGY - acute and chronic renal insufficiency, dysmetabolic nephropathy.
TOXICOLOGY - food poisoning, intoxication caused by alcohol, chemicals, aromatic hydrocarbons, heavy metal salts.
OBSTETRICS AND GYNAECOLOGY - pregnancy toxicosis, placental dysfunction, acute and chronic viral, bacterial and fungal vaginal infections.
PHARMACOLOGICAL PROPERTIES

Volume globular structure of Enterosgel (the frame depicts pore structure)

Enterosgel is of porous structure in the form of solid, spatially formed silicon organic matrix with specified pore dimensions, which preferentially secure the sorption of middle-molecule substances. This safeguards the said sorption detoxifying properties of Enterosgel as well as the selective action capacity.

Microphotograph of Enterosgel taken by electronic microscope

During its passage through the digestive tract, the product binds endogenous and exogenous toxic substances of various types, including bacteria and bacterial toxins, antigens, food allergens, medicaments, and their waste products, heavy metal salts and alcohol, and eliminates them from the body. The product also sorbs some metabolic products, including excessive quantities of bilirubin, urea, cholesterol, and lipid complexes as well as metabolites responsible for the development of endogenous toxicosis.

Enterosgel eliminates aromatic hydrocarbons and their derivatives, organic solvents and other industrial poisons, incorporated radionuclides from the body.

Enterosgel does not reduce the absorption of vitamins and trace elements, and helps to restore the diminished natural intestinal microflora. It does not affect the peristaltic activity of the intestines. 

Enterosgel destroys pathogenic microflora of the gastrointestinal tract and sorbs the following pathogens: Salmonellas, shigellae, klebsiellae and other gram negative and gram positive microorganisms and Candida fungi. Enterosgel does not diminish the normal, natural microflora of the intestinal tract. The selective effects of Enterosgel on microflora are explained by the fact that unlike the pathogenic microflora, the normal microflora has high affinity to the intestinal mucosa and thus adheres to it firmly. As a result of electrostatic interaction with Enterosgel, pathogenic microflora is disturbed and its particles are sorbed on the sorbent surface.

Enterosgel binds and eliminates viruses (rotaviruses, cytomegaloviruses and others).
Enterosgel eliminates allergens. Incomplete allergens are totally contained in the porous structure of Enterosgel. Complete allergens are sorbed on Enterosgel surface, which safeguards their elimination from the digestive tract and reduces the potential of possible allergic effects on the body.

ENTEROSGEL USE IN MEDICINE
The therapeutic effect of Enterosgel is based upon its ability to absorb substances which damage mucosal epithelium. This results in the normalisation of regenerative processes of the protective barrier of the mucosa and in reduced treatment duration for many a disease. The use of Enterosgel enables to achieve first treatment effects in a short time. This usually occurs on day 3-6 of treatment of a number of conditions.

A. Findings in individuals who did not use Enterosgel
Due to impaired microcirculation, mucosal oedema develops; sections with large and deep damage of erosive nature are obvious as well as minor multiple bleeding. The ultra-structure of column epithelia and other cells have been significantly compromised. Mitotic index has dropped 1.4 times, which evidences reduced proliferation and restoration of damaged epitheliocytes.

B. Findings in individuals who used Enterosgel
The microcirculation stream structure is maintained. Dystrophic alterations are less expressed, desquamation of epitheliocytes is not apparent.

GASTROENTEROLOGY
The application of Enterosgel in gastro-duodenal ulcerations helps to effectively eradicate Helicobacter pylori. In intestinal dysbiosis Enterosgel allows to achieve microflora normalisation within 10-12 days.
Enterosgel improves the subjective feelings of patients, reduces the duration of dyspeptic and painful syndrome as well as fever, and normalises the motility of the gastrointestinal tract.
In inflammatory processes and erosive ulcerations affecting the digestive tract, Enterosgel accelerates repair and regeneration processes in the mucosa.

SURGERY
In the case of acute surgical procedures, the performance of enterosorption with Enterosgel doubly reduces the level of microbial infection of the abdominal cavity and reduces the intestinal paresis. The number of post-operative complications is significantly lower.

INFECTIOUS DISEASES
In patients with intestinal infections, the temperature normalises on day one of treatment; bowel movements are normalised on day two. In viral hepatitis the positive effects demonstrate as improved subjective feelings and appetite, the itching sensation on the skin and weakness is reduced, on day 5-7 bilirubin and aminotranspherase concentrations decrease.

ALLERGOLOGY
In atopic dermatitis and other skin allergoses the positive effect can be observed as soon as 1-2 days following the start of Enterosgel application. The therapeutic process may be managed on average within 6-13 days. The inclusion of Enterosgel in the complex therapy for bronchial asthma enables to reduce the severity of the condition or to prevent its deterioration, to prolong the interval between attacks, and to normalise immunological factors and external breathing function factors.

NEPHROLOGY AND UROLOGY
The use of Enterosgel in the complex therapy of renal insufficiency effectively treats not only the intoxication syndrome, but also other signs of the disease – abdominal, dysuric syndrome and temperature reaction. As a result of treatment with Enterosgel, the toxic and metabolic load of the body is always reduced. The use of Enterosgel contributes to decreasing the acidosis and azotemia values in patients with nephrological conditions and complicated renal insufficiency. When Enterosgel is used, on day 10 – 12 creatinine and urea factors drop approx. 1.7 – 2.2 times, the hydrogen-carbonate potential of blood is restored, and renal ammoniagenesis is improved.

SORPTION DETOXIFICATION PROPERTIES
Enterosgel acts selectively and has high sorption capacity. It sorbs in particular toxic substances of middle-molecular mass. It does not cause lack of trace elements, calcium, vitamins and other beneficial substances.

MICROBIOCENOSIS NORMALISATION
Enterosgel destroys pathogenic microorganisms, eliminates exogenous and endogenous toxins produced during the lifetime activity and death of microorganisms. It helps to restore normal microflora.

RESTORATION OF DIGESTIVE TRACT MUCOSA
Enterosgel exhibits cytoprotective effects. It protects the mucosa from chemical and mechanical effects. It restores mucosa, microcirculation and physiological production of mucus. It helps to restore the immune protection of the mucosa, normalises the level of secretory immunoglobulin A.

SAFETY
Enterosgel is not absorbed in blood, it is non-toxic, has solid structure, and is chemically inert, does not adhere to mucosal surfaces and, unlike fine dispersion sorbents it is not absorbed in the body tissues. Enterosgel naturally leaves the body within 7 – 8 hours together with substances sorbed thereon. Long-term treatment with Enterosgel does not cause intestinal tract atony.

THE PRODUCT MAY BE USED BY PREGNANT WOMEN AND CHILDREN.
AVAILABLE FROM PHARMACIES WITHOUT PRESCRIPTION.